BTI
TTRX

Blue Trust Inc’s Turn Therapeutics TTRX Stock Holding History

Blue Trust Inc’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.19K Hold
1,122
– – ﹤0.01% 1913
2026
Q1 		$3.59K Hold
1,122
– – ﹤0.01% 2048
2025
Q4 		$4.42K Buy
+1,122
New +$4.68K ﹤0.01% 2015

Other funds holding TTRX

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $504M AUM 18.61% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return
PK
Pflug Koory Omaha, Nebraska $250M AUM 42.29% 1-Year Est. Return

Blue Trust Inc's TTRX Position: Q2 2026 in Review

Blue Trust Inc held its Turn Therapeutics (TTRX) position steady in Q2 2026 at 1,122 shares worth $8.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1913.

Blue Trust Inc first reported a position in TTRX in Q4 2025 and has held it in 3 quarters since. 7 funds tracked by Wall St. Rank hold TTRX as of Q2 2026.

  • Blue Trust Inc held 1,122 shares of Turn Therapeutics worth $8.19K as of Q2 2026.
  • Blue Trust Inc left its Turn Therapeutics share count unchanged in Q2 2026.
  • Turn Therapeutics made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1913 holding.
  • Blue Trust Inc first reported a position in Turn Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 7 funds tracked by Wall St. Rank held Turn Therapeutics as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.